Literature DB >> 6511092

Chloramphenicol-resistant Salmonella tennessee osteomyelitis.

W Kiess, R Haas, W Marget.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6511092     DOI： 10.1007/bf01651156

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  8 in total

1.  Eradication of Salmonella dublin in an immunodeficient child by combined use of ceftriaxone and ciprofloxacin after failure of either agent alone.

Authors:  J E Hoppe; R Dopfer; S Huber; D Niethammer
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

2.  Successful treatment with ciprofloxacin of Salmonella typhimurium infection in an immunocompromised host.

Authors:  S Esposito; G B Gaeta; D Galante; D Barba
Journal:  Infection       Date:  1985 Nov-Dec       Impact factor: 3.553

3.  Parenteral fluoroquinolones in children with life-threatening infections.

Authors:  R Dagan; F Schlaeffer; M Einhorn
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

Review 4.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 5.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 6.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

7.  Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children.

Authors:  H Peltola; M Väärälä; O V Renkonen; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 8.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.